Fig. 5
From: NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors
NHERF1 and NF2 expression in papillary metastatic carcinoma to the CNS. Representative cases of papillary thyroid carcinoma (67 year-old male), lung adenocarcinoma (71 year-old female), and serous ovarian carcinoma (43 year-old female) with papillary morphology assessed for IHC with NHERF1 and NF2 antibodies show apical plasma membrane localization of NHERF1 and a range of expression profiles for NF2. Note lack of NF2 basolateral plasma membrane staining in metastatic carcinomas, distinguishing these from CP tumors